Vaccine value profile for enterotoxigenic Escherichia coli (ETEC)
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- World Health Organization
- Bill and Melinda Gates Foundation (INV-005318)
This publication has 80 references indexed in Scilit:
- Refinement of a Human Challenge Model for Evaluation of Enterotoxigenic Escherichia coli VaccinesClinical and Vaccine Immunology, 2011
- A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)Vaccine, 2011
- Volunteer Challenge With Enterotoxigenic Escherichia coli That Express Intestinal Colonization Factor Fimbriae CS17 and CS19The Journal of Infectious Diseases, 2011
- Cost–Benefit of WC/rBS Oral Cholera Vaccine for Vaccination Against ETEC‐Caused Travelers’ DiarrheaJournal of Travel Medicine, 2009
- Development of a travelers’ diarrhea vaccine for the military: How much is an ounce of prevention really worth?Vaccine, 2008
- Disease Burden Due to Enterotoxigenic Escherichia coli in the First 2 Years of Life in an Urban Community in BangladeshInfection and Immunity, 2007
- Randomised, double-blind, safety and efficacy of a killed oral vaccine for enterotoxigenic E. Coli diarrhoea of travellers to Guatemala and MexicoVaccine, 2007
- Immune Response, Ciprofloxacin Activity, and Gender Differences after Human Experimental Challenge by Two Strains of Enterotoxigenic Escherichia coliInfection and Immunity, 2007
- Identification of a Two-Partner Secretion Locus of Enterotoxigenic Escherichia coliInfection and Immunity, 2006
- Policymakers’ views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in AsiaVaccine, 2005